Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

ATXN3 increases the amount of Ubiquitin. 1 / 1

| 1

➶

reach

"With anti-Ubi N antibody, we show that altering ataxin-3 levels did not affect the levels of ubiquitin moieties expressed in cells (XREF_FIG F, comparing input lanes 1 and 7, and lanes 4 and 10) or pulled down in the aggregates (XREF_FIG F, comparing lanes 3 and 9 and lanes 6 and 12), suggesting that ataxin-3 knockdown did not reduce the total level of ubiquitin expressed in cells or the ubiquitin associated with protein aggregates but only specifically reduced the amount of unanchored ubiquitin C termini in protein aggregates."

22069321

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...